Ibrutinib versus previous standard of care: an adjusted comparison in patients with relapsed/refractory chronic lymphocytic leukaemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ibrutinib versus previous standard of care: an adjusted comparison in patients with relapsed/refractory chronic lymphocytic leukaemia

Published:2017-07-31 Issue:10 Volume:96 Page:1681-1691
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Hansson Lotta,Asklid Anna,Diels Joris,Eketorp-Sylvan Sandra,Repits Johanna,Søltoft Frans,Jäger Ulrich,Österborg Anders

Funder

Janssen Cilag and Pharmacyclics, Inc

The Swedish Cancer Society

The Cancer Society in Stockholm

King Gustav V Jubilee Fund

The Cancer and Allergy Foundation

StratCan Karolinska Institutet

AFA Försäkring

The Stockholm County Council

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/article/10.1007/s00277-017-3061-3/fulltext.html

Reference22 articles.

1. Rozovski U, Hazan-Halevy I, Keating MJ, Estrov Z (2014) Personalized medicine in CLL: current status and future perspectives. Cancer Lett 352(1):4–14. doi: 10.1016/j.canlet.2013.07.013

2. Shvidel L, Tadmor T, Braester A, Bairey O, Rahimi-Levene N, Herishanu Y, Klepfish A, Ruchlemer R, Berrebi A, Polliack A, Israeli CLLSG (2014) Serum immunoglobulin levels at diagnosis have no prognostic significance in stage A chronic lymphocytic leukemia: a study of 1113 cases from the Israeli CLL Study Group. Eur J Haematol 93(1):29–33. doi: 10.1111/ejh.12290

3. Eichhorst B, Dreyling M, Robak T, Montserrat E, Hallek M, Group EGW (2011) Chronic lymphocytic leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 22(Suppl 6):vi50–vi54. doi: 10.1093/annonc/mdr377

4. Hallek M (2015) Chronic lymphocytic leukemia: 2015 update on diagnosis, risk stratification, and treatment. Am J Hematol 90(5):446–460. doi: 10.1002/ajh.23979

5. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64(1):9–29. doi: 10.3322/caac.21208

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Externally Controlled Studies Using Real-World Data in Patients With Hematological Cancers;JAMA Oncology;2024-08-29

2. Effect of designations of index date in externally controlled trials: an empirical example;Epidemiologic Methods;2024-01-02

3. Is this the end for immunochemotherapy in relapsed/refractory chronic lymphocytic leukemia?;Leukemia & Lymphoma;2023-03-10

4. Real‐world outcomes upon second‐line treatment in patients with chronic lymphocytic leukaemia;British Journal of Haematology;2023-03-10

5. Approaches to Selecting “Time Zero” in External Control Arms with Multiple Potential Entry Points: A Simulation Study of 8 Approaches;Medical Decision Making;2022-05-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3